Innovative drug development
Focus on innovative drugs for anti infection and inflammatory metabolism, layout lead compound screening, pharmacological evaluation, preclinical research, and promote the pipeline of innovative candidate drugs.
Hong Kong Biopharmaceuticals is laying out innovative drug research and development in areas such as anti infection and metabolic inflammation, covering target research, lead molecule screening, pharmacological and toxicological evaluation, formulation development, and preclinical pipeline promotion.
Pipeline concept: Focus on unmet clinical needs and steadily advance candidate molecular pipelines.
Scope of Business
- ✓Early detection and target validation of candidate new drugs
- ✓Optimization of drug molecules and development of formulation processes
- ✓Preclinical research protocol design and project management
Project Collaboration
Jointly developedTechnical authorizationEntrusted research and development
Partner With Us